Loss of post-translational modification sites in disease.
about
Candidate gene association studies: a comprehensive guide to useful in silico toolsDisease mutations in disordered regions--exception to the rule?Systematic functional prioritization of protein posttranslational modifications.Evolutionary constraint and disease associations of post-translational modification sites in human genomesThe acquisition of novel N-glycosylation sites in conserved proteins during human evolutionUsing bioinformatics to predict the functional impact of SNVsPhosphorylation of unique domains of Src family kinases.Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseasesChanges in predicted protein disorder tendency may contribute to disease riskExpanding the proteome: disordered and alternatively folded proteins.Proteome-wide analysis of single-nucleotide variations in the N-glycosylation sequon of human genesMechanistic insights into mammalian stress granule dynamics.Rampant purifying selection conserves positions with posttranslational modifications in human proteinsDetection and analysis of disease-associated single nucleotide polymorphism influencing post-translational modification.Systematic Analysis of the Genetic Variability That Impacts SUMO Conjugation and Their Involvement in Human Diseases.Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction InterfacesThe Loss and Gain of Functional Amino Acid Residues Is a Common Mechanism Causing Human Inherited DiseaseTowards precision medicine: advances in computational approaches for the analysis of human variantsHydrogen-exchange mass spectrometry for the study of intrinsic disorder in proteins.Posttranslational modifications of GLUT4 affect its subcellular localization and translocation.Prediction of post-translational modification sites using multiple kernel support vector machine.Phosphorylation of carboxypeptidase B1 protein regulates β-cell proliferation.Proteome-wide analysis of human disease mutations in short linear motifs: neglected players in cancer?ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins.Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer.Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter.Deficient O-GlcNAc Glycosylation Impairs Regulatory T Cell Differentiation and Notch Signaling in Autoimmune Hepatitis
P2860
Q26851744-A1420363-6921-4B8C-B323-FFCB14B9D8EDQ27025729-7C2F869E-9A57-43D8-B18F-E84A94EFE976Q27936051-4FA8A738-999F-4EA6-9142-1CA9FD7A3617Q28543059-850F1B47-D4AE-4897-B496-A7ED5B184DEFQ28650549-86D44BAB-3514-43C9-B3E1-58CDC6E0A37EQ28744088-589A4251-870E-46A4-92A0-C797FF1A80E4Q30009341-78E6DB68-5A04-46A0-BE34-164B9F6776FCQ33909288-E7F87CEB-015B-4507-9F9A-34E775354260Q34174016-B677C59E-F45A-42E9-8CF3-FFE30CBE7F04Q34197530-C7E57082-C55E-4EBB-97F4-C36BAC3E4C26Q34269085-5F50AA79-A476-4DE3-9B53-F1E38C17E975Q34544246-9CFF2543-27BB-4543-80B9-0739C0306DCEQ35023102-DA69C0EA-7FC9-4733-A5FB-C985DFD5794EQ35653101-60134D2F-00F0-4444-BE11-E0DFEA6B5BD9Q35830604-5FDF4DF6-A22E-4C93-B56F-FC506FC127BFQ35979091-3B5BE24F-8EC5-4DC8-B2D1-D385E0F434C0Q36114159-A5124C7C-32C2-47F6-83BE-B8F9867AA0C8Q37251907-9EB09189-C09D-4E85-9901-CDE45A632B34Q38055634-4ACB09AE-4328-4CA7-87C9-20E6A53CA3D6Q38105909-7F7FB3FB-1329-402F-9EA2-B4E0465AC838Q42040786-B5651F1A-9CB5-4EC0-930A-582764056B91Q42280193-33E2FC23-115C-4468-8E37-242C65AA0B08Q42673758-21CFBC4A-02F4-4274-B7FE-10C5B57F9288Q47150811-77EF513D-0D1E-43B9-B0C7-E4FB5FB8BCBEQ55053200-5B27C7B0-D52D-4052-81CC-0A53AEAB7D2CQ55066708-3DDE272A-FB11-455C-AF90-A052ED7E5A80Q57816684-19DBAA87-CF2B-4231-A825-9D3C3B9680E8
P2860
Loss of post-translational modification sites in disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Loss of post-translational modification sites in disease.
@en
Loss of post-translational modification sites in disease.
@nl
type
label
Loss of post-translational modification sites in disease.
@en
Loss of post-translational modification sites in disease.
@nl
prefLabel
Loss of post-translational modification sites in disease.
@en
Loss of post-translational modification sites in disease.
@nl
P2093
P2860
P1476
Loss of post-translational modification sites in disease.
@en
P2093
Lilia M Iakoucheva
Sean D Mooney
P2860
P304
P577
2010-01-01T00:00:00Z